Schonfeld Strategic Advisors LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1665241
NEW YORK, NY
Position in ADPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
12,796
-80.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $103,808,751 across 23 Diagnostics & Research names. ADPT ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
179,482 | $26,927,684 | |
| 2 | DHR |
Danaher Corp /De/
|
66,922 | $12,747,302 | |
| 3 | ICLR |
Icon PLC
|
54,575 | $9,480,223 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
43,449 | $8,395,215 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
5,774 | $7,376,342 | |
| 6 | RDNT |
RadNet, Inc.
|
115,308 | $7,111,044 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
11,852 | $5,942,118 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
7,723 | $4,065,696 |
All Filings in ADPT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 51,183 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 262,199 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 110,452 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | — | 20,944 | Shares | Sole | 2025-11-14 | |
| 2022-03-31 | — | 26,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | — | 36,200 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | — | 29,112 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | — | 50,000 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | — | 21,100 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||